2012 Society of Surgical Oncology Cancer Symposium

Matthew Stenger / April 15 2012 / 2012 Society of Surgical Oncology Cancer Symposium

Neoadjuvant Aromatase Inhibitor Therapy Converts Many Patients to Candidates for Breast-conserving Surgery

The American College of Surgeons Oncology Group (ACOSOG) Z1031 trial examined the effect of neoadjuvant aromatase inhibitor therapy on clinical response and breast-conservation rates in postmenopausal...

Breast Cancer

Matthew Stenger / May 15 2012 / 2012 Society of Surgical Oncology Cancer Symposium

Inhibition of SFRP2 Found to Inhibit Growth of Triple-negative Breast Tumors

Secreted frizzled related protein 2 (SFRP2), a protein that modulates the Wnt signaling pathway and is involved in embryonic development, has been thought to exert a tumor-suppressive effect via inhib...

Hepatobiliary Cancer

Matthew Stenger / May 15 2012 / 2012 Society of Surgical Oncology Cancer Symposium

Regional Infusion of Designer T Cells to Treat Intrahepatic Metastases

Designer T cells are modified from normal T cells to express specific immune receptors that allow them, via antibody-directed recognition or other mechanisms, to kill malignant cells bearing particula...

Aug

Today In Oncology

2012 Society of Surgical Oncology Cancer Symposium

Neoadjuvant Aromatase Inhibitor Therapy Converts Many Patients to Candidates for Breast-conserving Surgery

Inhibition of SFRP2 Found to Inhibit Growth of Triple-negative Breast Tumors

Regional Infusion of Designer T Cells to Treat Intrahepatic Metastases

FDA Approves Lenvatinib for Unresectable Hepatocellular Carcinoma

Issues in Doctor-Patient Discussions on Potential Harms of Lung Cancer Screening

VB4-845 Granted Fast Track Designation by FDA for Treatment of Non–Muscle Invasive Bladder Cancer

Basal Cell Carcinoma and Risk for Development of Other Cancers

Broad-Based Genomic Sequencing in Advanced NSCLC in the Community Oncology Setting

Enzalutamide Prolongs Metastasis-Free Survival in Patients With Nonmetastatic, Castration-Resistant Prostate Cancer

New Frontiers Being Explored in Multiple Myeloma

No Benefit of Adding Abiraterone to Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Increasing PSA

Apatinib and Oral Etoposide in Platinum-Resistant/Refractory Ovarian Cancer

Long-Term Pooled Safety Data for Palbociclib Combined With Endocrine Therapy in HR-Positive, HER2-Negative Breast Cancer

Gilberto Lopes, MD, MBA, on NSCLC: Results From the KEYNOTE-042 Trial

Gabriel N. Hortobagyi, MD, on Breast Cancer Staging: New and Important Changes

Jonathan W. Friedberg, MD, on Follicular Lymphoma: Novel Combination Therapies

Melinda Telli, MD, on Triple-Negative Breast Cancer: New Clinical Approaches

Sherry Shen, MD, on Breast Cancer and Obesity: Results of the SWOG S0927 Study